Lonza and EVA Pharma Sign Multi-Year Supply Agreement for Carnipure
L-Carnitine is a nutrient that plays an important role in fat and energy metabolism. It is produced in the body and can be found in some dietary sources, mostly of animal origin.
2/15/2011 --- EVA Pharma and Lonza have signed a multi-year supply agreement for Carnipure tartrate and Carnipure crystalline, two of Lonza’s L-Carnitine products, as well as a Carnipure brand licensing agreement. The signing of these contracts will further strengthen the collaboration between both companies.
“Thanks to Lonza’s continuous support, we have been able to establish Carnivita Forte as one of our best-selling products in the field of urology,” comments Dr. Riad Armanious, CEO of EVA Pharma. Carnivita Forte is an over-the-counter product meant for men wishing to promote their fertility by increasing sperm count and sperm motility. The product contains 1 g Carnipure tartrate per tablet.
L-Carnitine is a nutrient that plays an important role in fat and energy metabolism. It is produced in the body and can be found in some dietary sources, mostly of animal origin. L-Carnitine transports long-chain fatty acids into the cells’ mitochondria, where they are transformed into energy. Organs and cells with high energy demands, such as sperm, contain high levels of L-Carnitine upon which they depend for normal functionality.
“Extensive research shows that Carnipure supplementation may positively influence sperm quality or, more specifically, sperm count, sperm motility and the number of motile sperm, thus playing an important part in male fertility,” comments Ulla Freitas, Nutrition Science Team Leader at Lonza. Lonza is the world’s leading producer of L-Carnitine. Under the Carnipure brand, Lonza offers Carnipure crystalline, which is pure L-Carnitine, as well as Carnipure tartrate, a nonhygroscopic form made of L-Carnitine and tartaric acid. Products displaying the Carnipure quality seal on the packaging show the consumer that they contain pure L-Carnitine from Lonza.
